IE51498B1 - Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them - Google Patents

Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them

Info

Publication number
IE51498B1
IE51498B1 IE1860/81A IE186081A IE51498B1 IE 51498 B1 IE51498 B1 IE 51498B1 IE 1860/81 A IE1860/81 A IE 1860/81A IE 186081 A IE186081 A IE 186081A IE 51498 B1 IE51498 B1 IE 51498B1
Authority
IE
Ireland
Prior art keywords
pyridyl
substituted
acid addition
quinazoline
addition salts
Prior art date
Application number
IE1860/81A
Other languages
English (en)
Other versions
IE811860L (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IE811860L publication Critical patent/IE811860L/xx
Publication of IE51498B1 publication Critical patent/IE51498B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/06—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/44—Radicals substituted by doubly-bound oxygen, sulfur, or nitrogen atoms, or by two such atoms singly-bound to the same carbon atom
    • C07D213/46—Oxygen atoms
    • C07D213/50—Ketonic radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/06—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms
    • C07D233/08—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms
    • C07D233/12—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to ring carbon atoms with alkyl radicals, containing more than four carbon atoms, directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D233/16—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
IE1860/81A 1980-08-15 1981-08-14 Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them IE51498B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH619780 1980-08-15

Publications (2)

Publication Number Publication Date
IE811860L IE811860L (en) 1982-02-15
IE51498B1 true IE51498B1 (en) 1987-01-07

Family

ID=4305798

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1860/81A IE51498B1 (en) 1980-08-15 1981-08-14 Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them

Country Status (16)

Country Link
EP (1) EP0046446A1 (enrdf_load_stackoverflow)
JP (1) JPS5754186A (enrdf_load_stackoverflow)
KR (1) KR830006293A (enrdf_load_stackoverflow)
AU (1) AU7409281A (enrdf_load_stackoverflow)
CA (1) CA1173831A (enrdf_load_stackoverflow)
DD (1) DD201594A5 (enrdf_load_stackoverflow)
DK (1) DK362381A (enrdf_load_stackoverflow)
ES (1) ES8204992A1 (enrdf_load_stackoverflow)
FI (1) FI812518A7 (enrdf_load_stackoverflow)
GB (1) GB2082577B (enrdf_load_stackoverflow)
GR (1) GR78233B (enrdf_load_stackoverflow)
IE (1) IE51498B1 (enrdf_load_stackoverflow)
IL (1) IL63572A0 (enrdf_load_stackoverflow)
NO (1) NO812762L (enrdf_load_stackoverflow)
PT (1) PT73523B (enrdf_load_stackoverflow)
ZA (1) ZA815621B (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60188609A (ja) * 1984-03-07 1985-09-26 株式会社スリ−ボンド セルフロッキングねじ部材の製造方法
JPS61167711A (ja) * 1985-01-17 1986-07-29 株式会社　スリ−ボンド セルフロツキング剤及びセルフロツキングねじ部材
DE3730718A1 (de) * 1987-09-12 1989-03-23 Basf Ag Tetracyclische chinazolinderivate, herstellung und verwendung
US5212310A (en) * 1991-12-19 1993-05-18 Neurogen Corporation Certain aryl fused imidazopyrimidines; a new class of GABA brain receptor ligands

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH422807A (de) * 1963-08-16 1966-10-31 Wander Ag Dr A Verfahren zur Herstellung von Imidazo- und Pyrimidochinazolinen
US3329679A (en) * 1965-12-22 1967-07-04 American Home Prod Fused-ring imidazoquinazolines, pyrimidoquinazolines and related compounds

Also Published As

Publication number Publication date
GB2082577A (en) 1982-03-10
KR830006293A (ko) 1983-09-20
IE811860L (en) 1982-02-15
ES504736A0 (es) 1982-05-16
PT73523A (en) 1981-09-01
FI812518L (fi) 1982-02-16
ZA815621B (en) 1982-08-25
NO812762L (no) 1982-02-16
GB2082577B (en) 1984-03-28
PT73523B (en) 1983-08-16
JPS5754186A (enrdf_load_stackoverflow) 1982-03-31
ES8204992A1 (es) 1982-05-16
DK362381A (da) 1982-02-16
FI812518A7 (fi) 1982-02-16
GR78233B (enrdf_load_stackoverflow) 1984-09-26
IL63572A0 (en) 1981-11-30
EP0046446A1 (de) 1982-02-24
AU7409281A (en) 1982-02-18
DD201594A5 (de) 1983-07-27
CA1173831A (en) 1984-09-04

Similar Documents

Publication Publication Date Title
US5654309A (en) Pyridopyrimidine derivatives, their production and use
US3993656A (en) 1,8-Naphthyridine compounds
EP0132375B1 (en) Dihydropyridine anti-ischaemic and antihypertensive agents
EP0172029B1 (en) 1,4-dihydropyridines
EP0077983B1 (en) Triazine derivatives, processes for preparation thereof and pharmaceutical compositions comprising the same
CA1184910A (en) Tricyclic cytosine derivatives for combatting circulatory illnesses
KR870001269B1 (ko) 옥스인돌 카복스 아미드 유도체의 제조방법
KR900000371B1 (ko) 피페라지노이소티아졸론 및 이의 제조방법
US4292429A (en) Imidazole urea and amido compounds
US4406897A (en) 6-Aryl-4-hydrazinyl-s-triazin-2-ones
DE69029303T2 (de) 5-Triazolo(3,4-i)purinderivate
KR930005175B1 (ko) 4,7-디히드로티에노 [2,3-b] 피리딘 유도체의 제조방법
RU2116308C1 (ru) Триазолпиримидиновые производные и фармацевтическая композиция
US4639518A (en) Substituted quinazolinediones
IE51498B1 (en) Novel polyazaheterocyclic compounds,process for their manufacture and pharmaceutical preparations containing them
US4608375A (en) Quinazolinone derivatives, processes for the preparation thereof and pharmaceutical composition comprising the same
Bosin et al. Routes of functionalized guanidines. Synthesis of guanidino diesters
US3764600A (en) 1-substituted-quinazoline-2(1h)-thiones
US5114944A (en) 2-phenylpyrazolo[1,5-a]pyrimidine-3-acetic acid derivatives exhibiting therapeutic effects
EP0074229B1 (en) Triazole gastric anti-secretory agents
US3378564A (en) Certain pyridyl tetrazole derivatives
SE463154B (sv) 6-fenetylaminoalkyl-furo(3,4-c)pyridinderivat,framstaellning daerav och terapeutiska kompositioner innehaallande dem
US4021554A (en) 1,4-Oxathiino[2,3-c]pyrrole derivatives
US5077295A (en) Antipsychoic 4-(4-(3-benzisothiazolyl)-1-piperazinyl)buytl bridged bicycle imides
JPS62135475A (ja) ２−置換−ｅ−融合−〔１，２，４〕トリアゾロ−〔１，５−Ｃ〕ピリミジン